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carcinoma and 11.2% adenocarcinoma. Degree of differentiation: 37.3% G1–G2 and 37.4% G3. 25.2% Gx. External radiation ther-
apy was administered on pelvic±para-aortic, with parametrial boost if indicated (18.7%). Mean dose 46.7Gy, 1.8Gy/d (34–75). All
patients received chemotherapy with weekly CDDP, 40mg/m2. After treatment, 52.3% achieved complete response while 46.7%
were partial responses. 64 patients (59.8%) were salvaged surgically and 54 (84.4%) receiving brachytherapy later. 30 patients
continued with brachytherapy and 13 with external radiotherapy. Mean and standard deviation for quantitative variables and
absolute frequency and percentage for qualitative variables were obtained. The Kaplan–Meier method was used to estimate
patient survival.
Results. The median duration of follow-up was 39.5 months (7.2–178.6). OS at 3 and 5 years was 78.4% and 64.7% respectively. DFS
in the same periods was 60% and 55.6%. 22.4% patients had local disease recurrence and 25.2% metastases (nodal o visceral). RFS
at 3 and 5 years was 78.8% and 75.1% respectively while MFS was 72.3% and 68.8%. Acute toxicity: urinary, 22.5% G1 and 2.8% G2.
Gastrointestinal: 20.6% G1, 11.2% G2 and 0.9% G3. Late toxicity: urinary, 7.5% G1. Gastrointestinal: 1.8% G1–2.
Conclusion. Our results are similar to other historical series (Claire Vale et al., Meta-analysis). Radiochemotherapy for locally
advances cervical cancer providing good results in DFS and OS with good tolerance and low morbidity.
http://dx.doi.org/10.1016/j.rpor.2013.03.240
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Introduction. Radiation induced SIF is a fracture that results from normal stress applied to weakened bone due to radiotherapy (RT)
in pelvic malignancies. Sacroiliac joint is the most common involved site. Studies have shown a high variability about incidence
(range 3–89%). Latency since radiation to develop a fracture is known to occur between 1 and 190 months. Magnetic Resonance
Imaging (MRI) is currently the method of choice to evaluate SIF due to high sensitiveness. The aim of this article is to describe
SIF risk factors after pelvic RT and the usefulness of MRI technique.
Methods and materials. Data from 13 patients (all females) with pelvic cancer diagnosed as having radiation induced SIF were
reviewed retrospectively. The malignancies included cervical (10), endometrial (1) and rectal cancer (2). Median dose delivered
to whole pelvis was 54Gy (range 44–68). Risk factors including age, postmenopausal stage, diabetes, concurrent chemotherapy,
arterial hypertension and current smoking were recorded. MRI was used to diagnose SIF following RT due to its sensitiveness to
mild changes in bone marrow signal.
Results. Median age of 13 patients was 57 years (range 46–87). Predisposing factors included menopause (13/13), concomitant
chemotherapy (11/13), brachytherapy boost (11/13), current smoking (5/13), arterial hypertension (2/13), diabetes (1/13) and osteo-
porosis (1/13). Most common symptoms were diffuse low back pain radiating to the pelvis and sacral radiculopathy (up to 70%).
The radiological change most frequently seen in SIF was marrow edema. MRI ﬁndings presented as areas of high signal intensity
(SI) on T2 and STIR sequences and low SI on T1.
Conclusions. Pelvic radiotherapy can lead to sacral insufﬁciency fracturesmore likelywhenother comorbidities factors are present.
MRI has became the best imaging method to evaluate SIF in post-treated pelvic malignancies
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Aim. To evaluate the feasibility of radical radiotherapy after laparoscopic para-aortic lymphadenectomy for staging cervical
carcinoma (CC) patients stages IB-IIIB.
Methods. From March 2009 to December 2012, from 107 patients with CC treated, 62 underwent laparoscopic para-aortic lym-
phadenectomy for staging ﬁrst. Radiotherapy treatment was tailored according the results. External radiation therapy with
concurrent cisplatin (40mg/m2/sem) on cervical tumor and lymph nodes with concomitant para-aortic irradiation in nodes
positive patients, and high dose rate (HDR) brachytherapy boost.
Results. Mean age was 48.05(range, 28–69 years). Average of 13.36 lymph nodes were removed (range 2–34). Ten (16.1%) of 62
patients had metastatic disease in para-aortic nodes and received para-aortic treatment. Mean dose to pelvic volume was 49.5Gy
and 45.24Gy to para-aortic volume. HDR brachytherapy (intrauterine tandem and vaginal colpostates) was delivered in 4–5
fractions of 550–700 cGy. Both radiation procedures were planned with 3D CT guided dosimetry and MRI was used for image-
guided brachytherapy in the last patients.With amean follow-up time of 19months (range 1–43months) actuarial overall survival
